Role Description
The Clinical Team Lead II (CTL II) is a seasoned clinical operations professional with expertise in clinical project management, oncology research, and global regulatory compliance. This role is responsible for leading clinical study execution from startup through closeout, ensuring timelines, quality standards, and operational objectives are achieved.
The CTL II provides strategic oversight of Clinical Research Associates (CRAs), drives cross-functional collaboration, proactively manages study risks, and serves as a key contributor to the successful delivery of clinical trial milestones. A strong understanding of ICH-GCP, FDA regulations, and international research requirements is essential.
This is a remote position based in the US; relocation assistance, and visa sponsorship are not available.
Key Responsibilities
-
Participate in and present at Study Kickoff Meetings, Investigator Meetings, and other project-related meetings as needed.
-
Forecast and assess clinical resource needs to support study timelines, deliverables, quality expectations, and financial objectives.
-
Lead the planning, execution, and tracking of clinical activities throughout the lifecycle of assigned studies.
-
Identify, escalate, and support mitigation of project risks while collaborating across functions to drive effective resolution.
-
Develop, maintain, and oversee essential clinical project documentation, including study plans, trackers, and training materials.
-
Design and deliver study-specific training to internal teams and study personnel.
Qualifications
-
Bachelor’s degree in a scientific, healthcare, or related field.
-
Minimum of 5 years of experience in the clinical research industry, including experience in a clinical management or study leadership role.
-
2-3 years of direct oncology experience supporting Phase I and/or Phase II clinical trials.
-
Demonstrated ability to lead cross-functional initiatives and apply business acumen to achieve project goals and organizational objectives.
-
Strong knowledge of clinical trial operations, study design, and the drug development process.
-
Solid understanding of scientific, medical, and regulatory terminology.
-
Expert working knowledge of ICH-GCP guidelines and applicable regulatory requirements.
Requirements
-
Master’s degree in a scientific, healthcare, or related discipline (preferred).
-
7+ years of direct oncology experience supporting Phase I-II clinical trials across both solid tumors and hematologic malignancies (preferred).
-
Experience leading complex oncology studies in a CRO, sponsor, or biotech environment (preferred).
-
Proven success managing multiple studies and clinical teams in a fast-paced, matrixed organization (preferred).
Benefits
-
Comprehensive benefits to support physical, mental, and financial well-being.
-
Competitive compensation package determined by performance, experience, skills, equity, and geographical markets.
-
Additional compensation opportunities such as an annual bonus or long-term incentive opportunities may be offered.
Company Description
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development.
-
In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country.
-
Conducted more than 850 first-in-human clinical trials since its inception.
-
Contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade.
-
Research network brings together more than 1,300 physicians enrolling patients into clinical trials at more than 200 locations in 20+ states across the U.S.